Showing results (401-410 of 476) with videos related to

Sort By:
Pageof 48
Urology|August 30, 2024
Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?Ekamjit S Deol, Vidit Sharma, Anthony E Fadel, et al.
BJU International|August 5, 2016
Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomesSarah P Psutka, Mark Heidenreich, Stephen A Boorjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2008
Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinomaPaul L Crispen, Yuri Sheinin, Timothy J Roth, et al.
Urologic Oncology|July 7, 2020
Long-term outcomes of incidental prostate cancer at radical cystectomyVignesh T Packiam, Matvey Tsivian, Svetlana Avulova, et al.
European Urology|August 11, 2014
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal massesR Houston Thompson, Tom Atwell, Grant Schmit, et al.
Urology|August 16, 2019
Safety and Efficacy of Percutaneous Image-guided Cryoablation of Completely Endophytic Renal MassesCatherine A Murray, Brian T Welch, Grant D Schmit, et al.
The Journal of Urology|May 18, 2012
Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysisSimon P Kim, R Houston Thompson, Stephen A Boorjian, et al.
Journal of the American Society of Nephrology : JASN|September 17, 2020
Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney FunctionAleksandar Denic, Hisham Elsherbiny, Aidan F Mullan, et al.
European Urology|May 27, 2017
Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched AnalysisBimal Bhindi, Igor Frank, Ross J Mason, et al.
Urologic Oncology|December 14, 2020
Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinomaElizabeth N Bearrick, Vignesh Packiam, Bimal Bhindi, et al.
Pageof 48